MeSH tree: C19.246
The American Heart Association and the American College of Cardiology, along with two other leading medical organizations, have developed the first-ever guideline aimed at preventing and managing cardiovascular-kidney-metabolic ...
Jun 9, 2026
0
7
Over the past few years, GLP-1 drugs have transformed the treatment landscape for obesity and type 2 diabetes. By mimicking a hormone that helps regulate blood sugar, slows digestion and curbs appetite, these medications ...
Having a baby in the United States is about to get more complicated. Under new billing codes that take effect in January, doctors who manage maternity care will start charging à la carte for visits and services related to ...
Jun 8, 2026
0
3
One of the challenges public health officials face in reducing diet-related disease is the relatively easy and inexpensive access to sugar-sweetened beverages globally. To help address this burden, public health organizations ...
Jun 8, 2026
0
3
Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce bodyweight. At the American Diabetes Association's Scientific Session, Mass General Brigham physician investigator ...
Jun 8, 2026
0
29
A new study to be presented at the SLEEP 2026 annual meeting found that U.S. military veterans with both insomnia and obstructive sleep apnea face a markedly elevated risk of developing type 2 diabetes, substantially exceeding ...
Jun 8, 2026
0
4
A new study to be presented at the SLEEP 2026 annual meeting found that patients at high risk for obstructive sleep apnea who receive primary care in rural settings are less likely to be referred for sleep apnea evaluation ...
Jun 8, 2026
0
2
A new study led by researchers at the University of Texas at El Paso found that use of weight-loss drugs like Ozempic and other GLP-1s is associated with a lower risk of developing alcohol, opioid, nicotine and cocaine use ...
Jun 8, 2026
0
5
Rare genetic variants known to cause cardiomyopathy, an inherited cause of a weak heart, can increase the risk of patients developing heart failure. However, new research from Mass General Brigham Heart and Vascular Institute ...
Jun 8, 2026
0
24
A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset type 1 diabetes (T1D) in a mouse model of the disease. ...
Jun 7, 2026
0
24
